Hyderabad: DCA Raids Unlicensed Premises For Illegal Sell Of Steroids To Bodybuilders

Hyderabad:  Acting on credible information on the illegal sale of steroid medicines to gym-goers, the Drugs Control Administration, Telangana, raided an unlicensed premises operating under the name Rakesh Distributor at Esamia Bazar, Koti, and detected an unauthorized stock of a large quantity of steroid medicines for sale.

During the raids, the DCA officials found 22 varieties of steroid medicines, including androgen and anabolic steroids, stocked for sale at the premises, indicating the potential for abuse of steroid medicines.

The abuse of androgen and anabolic steroids poses significant health risks. These drugs, often misused by bodybuilders to enhance muscle growth, can lead to a range of adverse effects, including cardiovascular issues, liver damage, mood swings, and hormonal imbalances. Moreover, long-term abuse can result in severe health complications such as infertility, kidney failure, and psychiatric disorders, the DCA said.

Stock worth Rs. 2 lakhs were seized during the raid carried out by V. Ajay, Drugs Inspector, Goshamahal, and P. Santosh, Drugs Inspector, Mehdipatnam, and others.

In another instance, the DCA officials raided Srikanth Neurocentre, a hospital located at Miyapur, and found Dr. Boini Srikanth Yadav was illegally operating a medical shop in the hospital without a valid drug licence.

During the raid, unauthorized stocking of huge quantities of medicines for sale were detected and stocks of 31 varieties of medicines worth Rs. 1.01 lakhs were seized.

A. Shylaja Rani, Drugs Inspector, Serilingampally and D. Swetha Bindu, Drugs Inspector, Gandipet were among the officers who carried out the raid.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit